Neurology:神经节后超声检测的形态功能对比,有助于早期鉴别多系统萎缩(MSA-P)和帕金森病(PD)!

2022-02-11 Naomi MedSci原创

  近日,有研究人员定量评估了动态汗液试验和皮肤自主神经,这一方法提供了一个敏感的形态功能方法以评估神经节后泌汗神经通路的组成部分:相较于PD,上述部分在疾病过程早期更多参与MSA-P。

     ”帕金森综合症“定义了一些临床症状,主要是伴随强直、震颤和运动迟缓等运动症状。这其中包含原发性帕金森病(PD),以及其他不同发病机制、预后和药物治疗反应的更多罕见综合征,如多系统萎缩症(MSA)。

     帕金森综合症影响了65岁以上约2% 的人。缺乏改善疾病的治疗会导致严重的残疾,从而给全世界的卫生系统带来沉重的负担。在疾病过程中,症状和体征的出现和程度,以及随着时间的推移,更具体的神经影像特征的发展,可以分辨临床情况,并有助于达到既定的诊断标准以达到诊断。因此,即使对于运动障碍方面的专家,早期鉴别诊断仍是一项具有挑战性的任务。由于这些原因,能够帮助临床医生识别不同形式的帕金森综合征的早期生物标志物,是高度需要的。自主神经紊乱通常是帕金森综合征患者的主要症状,可以追溯到运动症状完全发展之前的许多年。泌汗神经障碍已被认为是一个关键特征,包括 MSA的节前和节后功能障碍,其严重程度与MSA小脑型相比更甚。然而,这些研究仅包括对疾病晚期患者的回顾性研究或前瞻性研究,而缺乏对疾病早期收缩功能障碍的前瞻性评价研究。

      近日,有研究人员评估了早期(运动发病2年内)MSA-P和PD患者的前瞻性形态学和功能性自主神经辅助器的受累情况,以确定可能的生物标志物,以确定可能有助于早期鉴别这两种疾病的生物标志物。

      研究包括100例自运动症状发作2年内出现帕金森综合征的患者。招募时,采用问卷调查法评估患者的非运动、自主神经和小纤维症状,采用动态汗液试验和远端穿刺皮肤活检法评估患者的神经节后超音速功能。皮肤样本经处理后,以去甲肾上腺素能及胆碱能抗体作为间接免疫荧光。应用专用软件在共聚焦图像上测量表皮内、支座和毛运动神经纤维的密度。在招募后12个月进行随访以确认诊断。

  • 57例 pd 患者(m/f = 36/21,年龄63.5 ± 9.4岁)和43例 MSA-P患者(m/f = 27/16,年龄62.3 ± 9.0岁)被纳入研究。
  • 临床量表和问卷显示MSA-P患者的临床症状较PD患者严重。
  • 出汗量和与对照组相比,两组的表皮内、毛运动神经和超毛运动神经密度都较低,但MSA-P患者的损害更大。
  • 毛运动神经和超长运动神经密度与出汗功能和非运动性临床症状相关。
  • 定义了汗液产生量乘以汗液纤维密度的算术乘积,有效地分离了两个种群,接收机工作特性曲线下面积为0.83。

      动态汗液试验和皮肤自主神经的定量提供了一个敏感的形态功能方法来评估神经节后泌汗神经通路的组成部分,揭示了一个更严重的参与MSA-P比PD在疾病过程早期。这种方法可以用来早期区分这两种情况。

证据分类: 这项研究提供了 ii 类证据,神经节后形态功能评估准确地区分PD与MSA-P患者。

文献来源:Provitera V, Iodice V, Manganelli F, et al. Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study [published online ahead of print, 2022 Jan 11]. Neurology. 2022;10.1212/WNL.0000000000013300. doi:10.1212/WNL.0000000000013300

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2001724, encodeId=358f2001e2425, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jun 29 08:06:00 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696035, encodeId=bdbc1696035e3, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Sep 08 00:06:00 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195383, encodeId=d31c1195383ef, content=坚持学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sun Feb 20 16:31:09 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195203, encodeId=b7011195203bb, content=学习<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:29:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194156, encodeId=e17611941560f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Wed Feb 16 21:29:13 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462636, encodeId=ccb41462636f4, content=<a href='/topic/show?id=af28433e5e1' target=_blank style='color:#2F92EE;'>#多系统萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43375, encryptionId=af28433e5e1, topicName=多系统萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0066497006, createdName=珙桐, createdTime=Sun Feb 13 15:06:00 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-06-29 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2001724, encodeId=358f2001e2425, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jun 29 08:06:00 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696035, encodeId=bdbc1696035e3, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Sep 08 00:06:00 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195383, encodeId=d31c1195383ef, content=坚持学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sun Feb 20 16:31:09 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195203, encodeId=b7011195203bb, content=学习<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:29:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194156, encodeId=e17611941560f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Wed Feb 16 21:29:13 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462636, encodeId=ccb41462636f4, content=<a href='/topic/show?id=af28433e5e1' target=_blank style='color:#2F92EE;'>#多系统萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43375, encryptionId=af28433e5e1, topicName=多系统萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0066497006, createdName=珙桐, createdTime=Sun Feb 13 15:06:00 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-09-08 chendoc252
  3. [GetPortalCommentsPageByObjectIdResponse(id=2001724, encodeId=358f2001e2425, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jun 29 08:06:00 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696035, encodeId=bdbc1696035e3, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Sep 08 00:06:00 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195383, encodeId=d31c1195383ef, content=坚持学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sun Feb 20 16:31:09 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195203, encodeId=b7011195203bb, content=学习<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:29:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194156, encodeId=e17611941560f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Wed Feb 16 21:29:13 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462636, encodeId=ccb41462636f4, content=<a href='/topic/show?id=af28433e5e1' target=_blank style='color:#2F92EE;'>#多系统萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43375, encryptionId=af28433e5e1, topicName=多系统萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0066497006, createdName=珙桐, createdTime=Sun Feb 13 15:06:00 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-02-20 杨海东

    坚持学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2001724, encodeId=358f2001e2425, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jun 29 08:06:00 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696035, encodeId=bdbc1696035e3, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Sep 08 00:06:00 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195383, encodeId=d31c1195383ef, content=坚持学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sun Feb 20 16:31:09 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195203, encodeId=b7011195203bb, content=学习<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:29:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194156, encodeId=e17611941560f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Wed Feb 16 21:29:13 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462636, encodeId=ccb41462636f4, content=<a href='/topic/show?id=af28433e5e1' target=_blank style='color:#2F92EE;'>#多系统萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43375, encryptionId=af28433e5e1, topicName=多系统萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0066497006, createdName=珙桐, createdTime=Sun Feb 13 15:06:00 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2001724, encodeId=358f2001e2425, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jun 29 08:06:00 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696035, encodeId=bdbc1696035e3, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Sep 08 00:06:00 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195383, encodeId=d31c1195383ef, content=坚持学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sun Feb 20 16:31:09 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195203, encodeId=b7011195203bb, content=学习<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:29:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194156, encodeId=e17611941560f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Wed Feb 16 21:29:13 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462636, encodeId=ccb41462636f4, content=<a href='/topic/show?id=af28433e5e1' target=_blank style='color:#2F92EE;'>#多系统萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43375, encryptionId=af28433e5e1, topicName=多系统萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0066497006, createdName=珙桐, createdTime=Sun Feb 13 15:06:00 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-02-16 red咩

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2001724, encodeId=358f2001e2425, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jun 29 08:06:00 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696035, encodeId=bdbc1696035e3, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Sep 08 00:06:00 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195383, encodeId=d31c1195383ef, content=坚持学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sun Feb 20 16:31:09 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195203, encodeId=b7011195203bb, content=学习<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:29:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194156, encodeId=e17611941560f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Wed Feb 16 21:29:13 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462636, encodeId=ccb41462636f4, content=<a href='/topic/show?id=af28433e5e1' target=_blank style='color:#2F92EE;'>#多系统萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43375, encryptionId=af28433e5e1, topicName=多系统萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0066497006, createdName=珙桐, createdTime=Sun Feb 13 15:06:00 CST 2022, time=2022-02-13, status=1, ipAttribution=)]

相关资讯

Annals of Neurology:帕金森步态障碍,皮层活动可参与补偿性步态改善

补偿策略的应用导致皮层活动与无提示步态相比发生变化,这不能完全归因于提示方式的感觉处理

Neurology:前瞻性队列研究: 多多摄入类黄酮,或改善帕金森病患者死亡率!

近日,研究人员前瞻性地研究诊断前后类黄酮摄入量与PD患者死亡风险之间的关系。在PD患者中,黄酮类化合物的摄入量较高,尤其是花青素和黄酮 -3- 醇,以及富含黄酮类化合物的食物,或与PD死亡率更低有关。

JPD:筛查4000文献,帕金森疾病,精神症状表现,有哪些?

大约有五分之一的PD患者会出现精神病或幻觉

Neurology:坚持高水平体育锻炼与早期帕金森病临床进程密切相关!

近日,有研究人员试图探讨有规律的身体活动和锻炼习惯对帕金森病的长期影响。从长远来看,保持较高的有规律的体育活动水平和运动习惯与帕金森病的临床进程密切相关,不同类型的体育活动具有不同的效果。

JPD:环境和遗传 因素,相互作用可影响帕金森病

PD与环境因素之间的关系可以得到证实。

Annals of Neurology:帕金森,经常有氧锻炼可改善认知功能

有氧运动能稳定皮质脑区感觉运动网络的疾病进展,并能提高认知能力。

拓展阅读

自主神经紊乱与收缩压变异相关

 来自上海高血压研究所的一项合作研究(X-CELLENT研究)显示,原发性高血压患者的自主神经功能紊乱与昼夜收缩压(SBP)梯度和SBP变异增加相关。   研究在第21届欧洲高血压和心血管预防会议(ESH 2011)上报告(口头报告会议9A:临床试验。摘要号:9A.03)。   X-CELLENT研究的2370例受试者中,年龄为(59.0±10.2)岁的579例患者被随机选取参与动态